
Avinogen is a biotechnology company that produces innovative gene-edited birds and useful substances based on its unique capabilities in avian biotechnology.

Avinogen is a global bio-innovation company developing high-value avian breeds and therapeutic proteins based on its unique avian germ cell gene-editing technology.
Avinogen is pioneering a new frontier in the bio industry through avian gene-editing technology, ranging from the production of therapeutic proteins to the development of disease-resistant and high-performance new breeds.
Building a high-value platform that connects the pharmaceutical, food, and biomaterial industries based on world-class avian biotechnology capabilities, Avinogen is leading a new paradigm in future biotechnology.